Back

Fresenius Medical Care to book €110 million China strategy charges in Q3 2026

Verifying
  • Fresenius Medical Care is refocusing its China business on advanced dialysis and critical-care products.
  • €110 million in one-time charges are expected during the third quarter of 2026.
  • The company will exit China’s peritoneal dialysis sector while honoring existing obligations.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.